×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PACB – pacific biosciences of california, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PACB
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
03:43 pm
pacb
Why PacBio (PACB) Stock Is Up Today [Yahoo! Finance]
Low
Report
Why PacBio (PACB) Stock Is Up Today [Yahoo! Finance]
11/28
10:01 am
pacb
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/28
09:05 am
pacb
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
PacBio to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/28
02:23 am
pacb
How Recent Moves Are Rewriting the Story for PacBio Amid Shifting Analyst Sentiment [Yahoo! Finance]
Low
Report
How Recent Moves Are Rewriting the Story for PacBio Amid Shifting Analyst Sentiment [Yahoo! Finance]
11/17
08:42 am
pacb
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization [Yahoo! Finance]
Low
Report
Broken String Biosciences Announces New Leadership to Drive Commercialization of INDUCE-seq® Platform for Gene Editing On- and Off-target Characterization [Yahoo! Finance]
11/14
01:10 pm
pacb
Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform [Yahoo! Finance]
Low
Report
Volta Labs and New England Biolabs Partner to Expand Automated NGS Library Preparation on the Callisto Platform [Yahoo! Finance]
11/12
03:35 pm
pacb
Why PacBio (PACB) Shares Are Getting Obliterated Today [Yahoo! Finance]
Low
Report
Why PacBio (PACB) Shares Are Getting Obliterated Today [Yahoo! Finance]
11/12
02:45 pm
pacb
Volta Labs Delivers the Ultimate Whole Genome Sequencing Sample Prep Launch: Callisto™ Now Unifies the Entire WGS Ecosystem on One Platform [Yahoo! Finance]
Neutral
Report
Volta Labs Delivers the Ultimate Whole Genome Sequencing Sample Prep Launch: Callisto™ Now Unifies the Entire WGS Ecosystem on One Platform [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/5/2025
04:02 pm
PACB
pacific biosciences of california, inc.
BEAT
Report
-7.8%
pacific biosciences of california, inc.
8/7/2025
04:05 pm
PACB
pacific biosciences of california, inc.
BEAT
Report
7.1%
pacific biosciences of california, inc.
5/8/2025
04:15 pm
PACB
pacific biosciences of california, inc.
BEAT
Report
-7.3%
pacific biosciences of california, inc.
2/13/2025
04:05 pm
PACB
pacific biosciences of california, inc.
IN-LINE
Report
24.2%
pacific biosciences of california, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:17 pm
pacb
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: MADRONE CAPITAL PARTNERS, LLC
Low
Report
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: MADRONE CAPITAL PARTNERS, LLC
11/6
04:05 pm
pacb
Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30
Low
Report
Form 10-Q PACIFIC BIOSCIENCES OF For: Sep 30
11/5
04:04 pm
pacb
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 05
Medium
Report
Form 8-K PACIFIC BIOSCIENCES OF For: Nov 05
11/4
04:59 pm
pacb
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: ARK Investment Management LLC
Medium
Report
Form SCHEDULE 13G/A PACIFIC BIOSCIENCES OF Filed by: ARK Investment Management LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Pacific Biosciences down 19% after patent ruling [Seeking Alpha]
14.8%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
3/16 Form 4 PACIFIC BIOSCIENCES OF For: Mar 16 Filed by: HENRY CHRISTIAN O 13.3%
3/24 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. 8.5%
4/28 Form DEF 14A PACIFIC BIOSCIENCES OF For: Apr 28 7.9%
3/5 Christian Henry Appointed Chairman of Pacific Biosciences’ Board of Directors 6.5%
4/8 Pacific Biosciences Powers SARS-CoV-2 Research at Commercial, Academic and Government Labs 5.3%
10/15 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at Piper Jaffray Companies from a "neutral" rating to an "overweight" rating. 5.1%
6/18 Form 8-K PACIFIC BIOSCIENCES OF For: Jun 18 4.9%
2/27 Pacific Biosciences of California (NASDAQ: PACB) was downgraded by analysts at BidaskClub from a "sell" rating to a "strong sell" rating. 3.5%
4/2 Form 3 PACIFIC BIOSCIENCES OF For: Apr 01 Filed by: Zaccarin Denis 3.4%
TOP News Decliners
2/6
Pacific Biosciences of California, Inc. (PACB) CEO Mike Hunkapiller on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha]
-11.6%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
2/10 Form SC 13G/A PACIFIC BIOSCIENCES OF Filed by: BlackRock Inc. -9.9%
2/25 Form 4 PACIFIC BIOSCIENCES OF For: Feb 19 Filed by: BARNES SUSAN K -9.9%
2/20 Form 4 PACIFIC BIOSCIENCES OF For: Feb 18 Filed by: BARNES SUSAN K -6.5%
8/13 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -5.3%
2/24 Form 4 PACIFIC BIOSCIENCES OF For: Feb 20 Filed by: Hunkapiller Michael -5.1%
12/16 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.9%
11/7 Q3/2019 9/30/2019 EPS -0.190 ZacksConsensus -0.140 ActVsEst (0.050) - Miss -3.7%
11/4 Pacific Biosciences of California (NASDAQ: PACB) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -2.4%
9/26 Form 8-K PACIFIC BIOSCIENCES OF For: Sep 25 -2.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: